公司资料
DURECT Corporation 股价、新闻与催化剂
- 股票代码:
- DRRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for DRRX.
公司概览
业务概览
DURECT was a specialty pharmaceutical company focused on pain, liver disease, and drug-delivery programs before its restructuring and public-market decline. Its story centered on trying to commercialize niche assets.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, DURECT sat in specialty biopharma.
商业模式特征
The business depended on product development, delivery technology, and the chance to create value from a narrow portfolio.
生物医药行业定位
DURECT belongs to the historical specialty-pharma set rather than the current live public-company universe.
未来催化剂
- DURECT’s catalysts are legacy and transaction-related, with any remaining asset-resolution or capital-update milestone doing the work. The company is no longer a live pipeline name.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。